Advanced Medical Solutions Group (LON:AMS) Reaches New 52-Week High – What’s Next?

Advanced Medical Solutions Group plc (LON:AMS)’s share price reached a new 52-week high during trading on Thursday . The stock traded as high as GBX 279.50 and last traded at GBX 278.50, with a volume of 134323438 shares. The stock had previously closed at GBX 240.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Berenberg Bank reissued a “buy” rating and issued a GBX 300 price target on shares of Advanced Medical Solutions Group in a research note on Tuesday, May 19th. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a GBX 260 price target on shares of Advanced Medical Solutions Group in a report on Thursday, April 9th. Three research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Advanced Medical Solutions Group presently has an average rating of “Moderate Buy” and a consensus price target of GBX 270.25.

Advanced Medical Solutions Group Stock Performance

The company has a debt-to-equity ratio of 31.50, a quick ratio of 4.58 and a current ratio of 2.79. The stock has a market capitalization of £605.03 million, a PE ratio of 61.62, a P/E/G ratio of 5.00 and a beta of 0.71. The firm has a 50 day moving average of GBX 231.69 and a 200-day moving average of GBX 217.86.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.